Page last updated: 2024-12-08
4-nitrophenyl beta-cellobioside
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
4-nitrophenyl beta-cellobioside: RN given refers to (beta)-isomer; see also (alpha)-anomer: 17400-77-0 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 165125 |
| CHEMBL ID | 350466 |
| MeSH ID | M0105496 |
Synonyms (38)
| Synonym |
|---|
| p-nitrophenyl beta-cellobioside |
| cellobioside, p-nitrophenyl (7ci) |
| 3482-57-3 |
| p-nitrophenyl cellobioside |
| beta-d-glucopyranoside, 4-nitrophenyl 4-o-beta-d-glucopyranosyl- |
| para-nitrophenyl beta-d-cellobioside |
| beta-d-glucopyranoside, 4-nitrophenyl 4-o-beta-d-glucopyranosyl- (9ci) |
| cellobioside, p-nitrophenyl, beta-d- (8ci) |
| 4-nitrophenyl beta-cellobioside |
| 4-nitrophenyl beta-d-cellobioside |
| pnpc |
| p-nitrophenyl beta-d-cellobioside |
| 4-nitrophenyl beta-d-cellobioside, >=98% (tlc) |
| 4-nitrophenyl-beta-d-cellobioside |
| CHEMBL350466 |
| (2s,3r,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-(4-nitrophenoxy)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol |
| p-nitrophenyl-beta-d-cellobioside |
| 4-nitrophenyl |a-d-cellobioside |
| AKOS015896873 |
| 4-nitrophenyl-beta-d-cellobiopyranoside |
| mfcd00069845 |
| AS-61338 |
| p-nitrophenyl n-acetyl-beta-d-cellobiopyranoside |
| IAYJZWFYUSNIPN-KFRZSCGFSA-N |
| (2s,3r,4s,5s,6r)-2-((2r,3s,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-(4-nitrophenoxy)tetrahydro-2h-pyran-3-yloxy)-6-(hydroxymethyl)tetrahydro-2h-pyran-3,4,5-triol |
| b-d-glucopyranoside, 4-nitrophenyl4-o-b-d-glucopyranosyl- |
| 4-nitrophenyl beta-d-cellobiopyranoside |
| A903640 |
| D97694 |
| 4-nitrophenyl beta -d-cellobioside |
| p-nitrophenyl ?-d-cellobioside |
| HY-137827 |
| CS-0142303 |
| wurcs=2.0/2,2,1/[a2122h-1b_1-5_1*o(c^ec^zc^ec^ec^zc^e$3)/6no/9=o][a2122h-1b_1-5]/1-2/a4-b1 |
| (2s,3r,4s,5s,6r)-2-{[(2r,3s,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-(4-nitrophenoxy)oxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol |
| PD063974 |
| AKOS040756238 |
| 4-nitrophenyl ??-d-cellobioside |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Bioassays (8)
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID190824 | Total activity of the entire contents of DSI segment in rat intestine | 1985 | Journal of medicinal chemistry, Jan, Volume: 28, Issue:1 | Drug glycosides: potential prodrugs for colon-specific drug delivery. |
| AID190825 | Total activity of the entire contents of PSI segment in rat intestine | 1985 | Journal of medicinal chemistry, Jan, Volume: 28, Issue:1 | Drug glycosides: potential prodrugs for colon-specific drug delivery. |
| AID190826 | Total activity of the entire contents of cecum segment in rat intestine | 1985 | Journal of medicinal chemistry, Jan, Volume: 28, Issue:1 | Drug glycosides: potential prodrugs for colon-specific drug delivery. |
| AID191619 | Specific activity of the cecum segment in rat intestine | 1985 | Journal of medicinal chemistry, Jan, Volume: 28, Issue:1 | Drug glycosides: potential prodrugs for colon-specific drug delivery. |
| AID191617 | Specific activity of the DSI segment in rat intestine | 1985 | Journal of medicinal chemistry, Jan, Volume: 28, Issue:1 | Drug glycosides: potential prodrugs for colon-specific drug delivery. |
| AID191618 | Specific activity of the PSI segment in rat intestine | 1985 | Journal of medicinal chemistry, Jan, Volume: 28, Issue:1 | Drug glycosides: potential prodrugs for colon-specific drug delivery. |
| AID190827 | Total activity of the entire contents of stomach segment in rat intestine | 1985 | Journal of medicinal chemistry, Jan, Volume: 28, Issue:1 | Drug glycosides: potential prodrugs for colon-specific drug delivery. |
| AID191620 | Specific activity of the stomach segment in rat intestine | 1985 | Journal of medicinal chemistry, Jan, Volume: 28, Issue:1 | Drug glycosides: potential prodrugs for colon-specific drug delivery. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
Research
Studies (31)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 7 (22.58) | 18.7374 |
| 1990's | 12 (38.71) | 18.2507 |
| 2000's | 5 (16.13) | 29.6817 |
| 2010's | 7 (22.58) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 11.02
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.02) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 31 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||